A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.
Diesinger T, Lautwein A, Bergler S, Buckert D, Renz C, Dvorsky R, Buko V, Kirko S, Schneider E, Kuchenbauer F, Kumar M, Günes C, Genze F, Büchele B, Simmet T, Haslbeck M, Masur K, Barth T, Müller-Enoch D, Wirth T, Haehner T.
Diesinger T, et al.
Can J Gastroenterol Hepatol. 2021 Feb 2;2021:8854432. doi: 10.1155/2021/8854432. eCollection 2021.
Can J Gastroenterol Hepatol. 2021.
PMID: 33604316
Free PMC article.